These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 21915911)
1. Glucocerebrosidase gene mutations are associated with Parkinson's disease in Russia. Emelyanov A; Boukina T; Yakimovskii A; Usenko T; Drosdova A; Zakharchuk A; Andoskin P; Dubina M; Schwarzman A; Pchelina S Mov Disord; 2012 Jan; 27(1):158-9. PubMed ID: 21915911 [No Abstract] [Full Text] [Related]
2. Association between Parkinson's disease and glucocerebrosidase mutations in Brazil. Spitz M; Rozenberg R; Pereira Lda V; Reis Barbosa E Parkinsonism Relat Disord; 2008; 14(1):58-62. PubMed ID: 17703984 [TBL] [Abstract][Full Text] [Related]
3. Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy. De Marco EV; Annesi G; Tarantino P; Rocca FE; Provenzano G; Civitelli D; Cirò Candiano IC; Annesi F; Carrideo S; Condino F; Nicoletti G; Messina D; Novellino F; Morelli M; Quattrone A Mov Disord; 2008 Feb; 23(3):460-3. PubMed ID: 18074383 [TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease in patients and obligate carriers of Gaucher disease. Becker JG; Pastores GM; Di Rocco A; Ferraris M; Graber JJ; Sathe S Parkinsonism Relat Disord; 2013 Jan; 19(1):129-31. PubMed ID: 22940477 [TBL] [Abstract][Full Text] [Related]
5. Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation. Aharon-Peretz J; Badarny S; Rosenbaum H; Gershoni-Baruch R Neurology; 2005 Nov; 65(9):1460-1. PubMed ID: 16148263 [TBL] [Abstract][Full Text] [Related]
6. Glucocerebrosidase N370S and L444P mutations as risk factors for Parkinson's disease in Brazilian patients. Guimarães Bde C; Pereira AC; Rodrigues Fda C; dos Santos AV; Campos M; dos Santos JM; dos Santos FL; de Rosso AL; Nicaretta DH; Pereira JS; da Silva DJ; Della Coletta MV; Santos-Rebouças CB; Pimentel MM Parkinsonism Relat Disord; 2012 Jun; 18(5):688-9. PubMed ID: 22192918 [No Abstract] [Full Text] [Related]
8. Analysis of the glucocerebrosidase gene in Parkinson's disease. Sato C; Morgan A; Lang AE; Salehi-Rad S; Kawarai T; Meng Y; Ray PN; Farrer LA; St George-Hyslop P; Rogaeva E Mov Disord; 2005 Mar; 20(3):367-70. PubMed ID: 15517592 [TBL] [Abstract][Full Text] [Related]
9. Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population. Toft M; Pielsticker L; Ross OA; Aasly JO; Farrer MJ Neurology; 2006 Feb; 66(3):415-7. PubMed ID: 16476943 [TBL] [Abstract][Full Text] [Related]
10. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort. Winder-Rhodes SE; Evans JR; Ban M; Mason SL; Williams-Gray CH; Foltynie T; Duran R; Mencacci NE; Sawcer SJ; Barker RA Brain; 2013 Feb; 136(Pt 2):392-9. PubMed ID: 23413260 [TBL] [Abstract][Full Text] [Related]
11. Osteopontin polymorphic susceptibility factor for Parkinson's disease among patients with Gaucher disease. Ribner A; Altarescu G; Zimran A; Elstein D Mov Disord; 2011 Jun; 26(7):1341-3. PubMed ID: 21469198 [TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease and the heterozygous state for glucocerebrosidase mutations among Brazilians. Socal MP; Bock H; Michelin-Tirelli K; Hilbig A; Saraiva-Pereira ML; Rieder CR; Jardim LB Parkinsonism Relat Disord; 2009 Jan; 15(1):76-8. PubMed ID: 18358758 [No Abstract] [Full Text] [Related]
13. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Clark LN; Ross BM; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K Neurology; 2007 Sep; 69(12):1270-7. PubMed ID: 17875915 [TBL] [Abstract][Full Text] [Related]
14. Glucocerebrosidase mutations in a French-Canadian Parkinson's disease cohort. Noreau A; Rivière JB; Diab S; Dion PA; Panisset M; Soland V; Jodoin N; Langlois M; Chouinard S; Dupré N; Rouleau GA Can J Neurol Sci; 2011 Sep; 38(5):772-3. PubMed ID: 21856586 [No Abstract] [Full Text] [Related]
15. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. Aharon-Peretz J; Rosenbaum H; Gershoni-Baruch R N Engl J Med; 2004 Nov; 351(19):1972-7. PubMed ID: 15525722 [TBL] [Abstract][Full Text] [Related]
16. Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutations. Gan-Or Z; Giladi N; Orr-Urtreger A Brain; 2009 Oct; 132(Pt 10):e125. PubMed ID: 19502295 [No Abstract] [Full Text] [Related]
17. Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population. Rajput A; Vilariño-Güell C; Rajput ML; Ross OA; Soto-Ortolaza AI; Lincoln SJ; Cobb SA; Heckman MG; Farrer MJ; Rajput A Mov Disord; 2009 Dec; 24(16):2411-4. PubMed ID: 19890971 [TBL] [Abstract][Full Text] [Related]
18. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. Eblan MJ; Walker JM; Sidransky E N Engl J Med; 2005 Feb; 352(7):728-31; author reply 728-31. PubMed ID: 15716572 [No Abstract] [Full Text] [Related]
19. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. Zimran A; Neudorfer O; Elstein D N Engl J Med; 2005 Feb; 352(7):728-31; author reply 728-31. PubMed ID: 15719452 [No Abstract] [Full Text] [Related]
20. Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Clark LN; Nicolai A; Afridi S; Harris J; Mejia-Santana H; Strug L; Cote LJ; Louis ED; Andrews H; Waters C; Ford B; Frucht S; Fahn S; Mayeux R; Ottman R; Marder K Mov Disord; 2005 Jan; 20(1):100-3. PubMed ID: 15517591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]